Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

CENTRAL NERVOUS SYSTEM EFFECTS OF HYOSCINE IN MAN

Adrian M. Ostfeld and Alayne Aruguete
Journal of Pharmacology and Experimental Therapeutics July 1962, 137 (1) 133-139;
Adrian M. Ostfeld
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alayne Aruguete
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Hyoscine, in doses of 0.15 to 0.8 mg, was injected subcutaneously in 54 subjects to determine its effects on salivary functioning, the spontaneous EEG, the electroencephalographic "arousal" response to photostimulation, motor behavior, mood, and the ability to focus and maintain attention.

Hyoscine induced a moderate bradycardia and a marked decrease in salivation and in the duration of the EEG "arousal" response. These effects were maximal at 1 to 2 hours after administration of hyoscine but were no longer present at 4 hours.

Consistent behavioral effects of hyoscine in the EEG experiments were a decrease in spontaneous speech and movement and a significant decrease in the "Energetic" Scale of the Clyde Mood Scale. The spontaneous EEG exhibited a consistent shift toward lower amplitude of 5 to 8 cycles per second activity. The alpha index significantly decreased. The effects on these behaviors and the spontaneous EEG differed from those noted in2) above in that they were maximal at 3 to 4 hours after hyoscine administration and persisted for at least 4 to 7 hours.

We suggest that the depression of the EEG "arousal" response may be attributed to an action of hyoscine on the ascending reticular activating system, which occurs independently of the action on the spontaneous EEG rhythm.

In comparing the effects of two dose levels of hyoscine, larger doses were associated with a decrease in performance on behavioral tests involving the ability to maintain an attentive set. However, differential doses of arecoline and methacholine did not exert differential effects on these same measures. In doses which antagonized the effects of hyoscine on salivation, arecoline and methacholine did not antagonize the effects of hyoscine on these behaviors.

Footnotes

    • Received March 15, 1962.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 137, Issue 1
1 Jul 1962
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CENTRAL NERVOUS SYSTEM EFFECTS OF HYOSCINE IN MAN
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

CENTRAL NERVOUS SYSTEM EFFECTS OF HYOSCINE IN MAN

Adrian M. Ostfeld and Alayne Aruguete
Journal of Pharmacology and Experimental Therapeutics July 1, 1962, 137 (1) 133-139;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

CENTRAL NERVOUS SYSTEM EFFECTS OF HYOSCINE IN MAN

Adrian M. Ostfeld and Alayne Aruguete
Journal of Pharmacology and Experimental Therapeutics July 1, 1962, 137 (1) 133-139;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Mechanisms of 5-Hydroxytryptamine2A Receptor Activation of the Mitogen-Activated Protein Kinase Pathway in Vascular Smooth Muscle
  • Interactive Role for Neurosteroids in Ethanol Enhancement of γ-Aminobutyric Acid-Gated Currents from Dissociated Substantia Nigra Reticulata Neurons
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics